News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Winston Laboratories, Inc. Announces Licensing Agreement With Sanofi-Aventis (Canada). in Canada



11/7/2008 11:13:36 AM

VERNON HILLS, Ill.--(BUSINESS WIRE)--Winston Laboratories, Inc., a wholly owned subsidiary of Getting Ready Corporation (OTC: GTRY.OB), announced that on October 30, 2008 it entered into a licensing agreement with sanofi-aventis Canada Inc. for the Canadian rights to Winston’s proprietary transient receptor potential vanilloid (TRPV-1) modulator in formulations for topical application.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES